BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37314251)

  • 41. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
    Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
    Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic analysis of familial colorectal cancer in Israeli Arabs.
    Chen-Shtoyerman R; Theodor L; Harmati E; Friedman E; Dacka S; Kopelman Y; Sternberg A; Zarivach R; Bar-Meir S; Fireman Z
    Hum Mutat; 2003 Apr; 21(4):446-7. PubMed ID: 12655564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy.
    Urso E; Agostini M; Pucciarelli S; Rugge M; Bertorelle R; Maretto I; Bedin C; D'Angelo E; Mescoli C; Zorzi M; Viel A; Bruttocao G; Ferraro B; Erroi F; Contin P; De Salvo GL; Nitti D
    Tumour Biol; 2012 Jun; 33(3):857-64. PubMed ID: 22278153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer.
    Fernández-Rozadilla C; Álvarez-Barona M; Quintana I; López-Novo A; Amigo J; Cameselle-Teijeiro JM; Roman E; Gonzalez D; Llor X; Bujanda L; Bessa X; Jover R; Balaguer F; Castells A; Castellví-Bel S; Capellá G; Carracedo A; Valle L; Ruiz-Ponte C
    Sci Rep; 2021 May; 11(1):11135. PubMed ID: 34045552
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T
    Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.
    Goecke T; Schulmann K; Engel C; Holinski-Feder E; Pagenstecher C; Schackert HK; Kloor M; Kunstmann E; Vogelsang H; Keller G; Dietmaier W; Mangold E; Friedrichs N; Propping P; Krüger S; Gebert J; Schmiegel W; Rueschoff J; Loeffler M; Moeslein G;
    J Clin Oncol; 2006 Sep; 24(26):4285-92. PubMed ID: 16908935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
    Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
    Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
    Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
    Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
    Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
    J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The analysis for identifying large DNA fragment aberrations of MSH2 and MLH1 genes from familial colorectal cancer in China.
    Zhu M; Liu XR; Huang YQ; Yuan Y; Li JT; Zhang XM; Zhang YY; Wang YP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):603-6. PubMed ID: 16331552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.
    Kastrinos F; Steyerberg EW; Mercado R; Balmaña J; Holter S; Gallinger S; Siegmund KD; Church JM; Jenkins MA; Lindor NM; Thibodeau SN; Burbidge LA; Wenstrup RJ; Syngal S
    Gastroenterology; 2011 Jan; 140(1):73-81. PubMed ID: 20727894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive analysis of the
    Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E
    J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.
    Christensen LL; Kariola R; Korhonen MK; Wikman FP; Sunde L; Gerdes AM; Okkels H; Brandt CA; Bernstein I; Hansen TV; Hagemann-Madsen R; Andersen CL; Nyström M; Ørntoft TF
    Fam Cancer; 2009; 8(4):489-500. PubMed ID: 19697156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Abu Hassan MR; Singh H; Naik VR; Ankathil R
    World J Gastroenterol; 2012 Feb; 18(8):814-20. PubMed ID: 22371642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
    Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
    Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.